Inhibrx, Inc. (INBX)
NasdaqGM - NasdaqGM 即時價格。貨幣為 USD。
加入追蹤清單
收市：04:00PM EDT
收市後：
正在載入互動式股價圖表...
- Zacks
Inhibrx, Inc. (INBX) Reports Q4 Loss, Tops Revenue Estimates
Inhibrx, Inc. (INBX) delivered earnings and revenue surprises of -61.68% and 1,534%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Pharma Stock Roundup: JNJ Reports Q4 Earnings, SNY Inks M&A Deal With INBX
J&J (JNJ) beats estimates for fourth-quarter earnings and sales. Sanofi (SNY) is set to acquire Inhibrx's (INBX) rare disease pipeline candidate, INBRX-101.
- Zacks
Biotech Stock Roundup: GILD Down on Study Results, INBX Gains on Sanofi Deal & More
Gilead Sciences (GILD) and Inhibrx (INBX) are in the spotlight on regulatory and pipeline updates.
